Anna Zekavati is lab head of the Imperial BRC Genomics Facility that provides infrastructure and state-of-the-art services for high-throughput genomic research. The Facility offers a wide range of next generation sequencing services from upstream experimental design to library preparation, sequencing and data anlysis, enabling users to select the service that is most suitable for their project. The laboratory is equipped with Illumina HiSeq2500 and MiSeq sequencers.
She obtained her Ph.D. in Molecular Immunology from the University of Kings College London in 2009. She completed a postdoctoral fellowship at the UCL Institute of Child Health, investigating the genetic causes of hypertrophic cardiomyopathy using next-generation sequencing; and joined Imperial College London in November 2012 as the head of the genomics lab. The facility is part of the Department of Medicine (Division of Diabetes, Endocrinology and Metabolism) and is funded by the NIHR through the Imperial Biomedical Research Centre as part of the Genetics and Genomics Theme.
et al., 2018, Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India., Vaccine, Vol:36, Pages:264-272
et al., 2015, Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism, Plos One, Vol:10, ISSN:1932-6203
et al., 2015, Association of polygenic genetic risk score with BMI is modified by the presence of deleterious alleles in monogenic obesity genes, Annals of Nutrition and Metabolism, Vol:67, ISSN:0250-6807, Pages:48-49
et al., 2014, Post-Transcriptional Regulation of BCL2 mRNA by the RNA-Binding Protein ZFP36L1 in Malignant B Cells, Plos One, Vol:9, ISSN:1932-6203
et al., 2013, High-throughput genotyping and phenotyping reveals new genetic determinants of clinical phenotype in hypertrophic cardiomyopathy, WILEY-BLACKWELL, Pages:S1-S1, ISSN:1388-9842